| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/26/2007 | EP1835926A2 Plasmin-inhibitory therapies |
| 09/26/2007 | EP1554250B1 Novel lactams and uses thereof |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1047708B1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center |
| 09/26/2007 | CN101044157A Compounds for proteasome enzyme inhibition |
| 09/26/2007 | CN100339389C 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273851 Tri-peptide hepatitis C serine protease inhibitors |
| 09/25/2007 | US7273614 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 09/25/2007 | US7273613 Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders |
| 09/25/2007 | CA2256516C Peptides |
| 09/25/2007 | CA2253506C Esculetin derivatives |
| 09/20/2007 | WO2007105650A1 4-hydroxyisoleucine derivative and process for producing the derivative |
| 09/20/2007 | WO2007085461A3 Anticoagulation of human blood ex vivo |
| 09/20/2007 | WO2007071625A3 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 09/20/2007 | WO2004009834A3 Novel nucleic acids and secreted polypeptides |
| 09/20/2007 | US20070219354 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070219140 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 09/20/2007 | US20070219138 Compositions capable of reducing elevated blood urea concentration |
| 09/20/2007 | US20070218525 Process for Producing Dipeptides |
| 09/20/2007 | US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof |
| 09/20/2007 | CA2649261A1 Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent |
| 09/19/2007 | EP1833978A1 Tripeptide and tetrapeptide thioethers |
| 09/19/2007 | EP1833846A2 Method for production of a therapeutically pure granulocyte macrophage - colony stimulating factor |
| 09/19/2007 | EP1833842A1 Tripeptide and tetrapeptide sulfones |
| 09/19/2007 | EP1833788A1 Process for preparing perindopril erbumine |
| 09/19/2007 | CN101039954A Solid phase peptide sythesis |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/18/2007 | US7271148 Inhibition of cellular proteases |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7271143 Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy |
| 09/18/2007 | US7270980 Diagnosing prostate cancer in humans; obtain sample, incubate with preferential binding agent, detect bound protein, bound protein indicates prostate cancer |
| 09/18/2007 | US7270962 Screening for agonist or antagonist to axon outgrowth inhibitors for use in prevention and designing treatments for brain, stroke and spinal injured individuals |
| 09/18/2007 | CA2144477C Pna synthesis using an amino protecting group which is labile to weak acids |
| 09/13/2007 | WO2007102563A1 Method for determination of the effect of thrombin receptor antagonist by determination of inflammatory marker |
| 09/13/2007 | WO2007102229A1 Guadinomine substance and method for producing the same |
| 09/13/2007 | WO2007101882A1 Tropolone- and hydroxybenzene-substituted oligopeptides for depigmentation |
| 09/13/2007 | US20070213506 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins |
| 09/13/2007 | US20070213505 Solution Synthesis of Peptide Cell Growth Stimulators |
| 09/13/2007 | US20070213276 A water soluble oligopeptide consisting of glycyl-prolyl-isoleucyl-glycyl-serine or glycyl-prolyl-isoleucyl-glycyl-threonine; hair growth-promoting effect, skin regeneration-promoting effect, therapeutic effect on skin ulcer, and therapeutic effect on mucosal injury |
| 09/13/2007 | DE102006011883A1 Tropolon- und Hydroxybenzol-substituierte Oligopeptide zur Depigmentierung Tropolon- and hydroxybenzene substituted oligopeptides depigmentation |
| 09/13/2007 | CA2644952A1 Methods and compositions related to cyclic peptide synthesis |
| 09/12/2007 | EP1831243A2 Antibody binding affinity ligands |
| 09/12/2007 | EP1830867A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1442296A4 Biological assay detection method |
| 09/12/2007 | CN101035802A Inhibitors of IAP |
| 09/12/2007 | CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 09/12/2007 | CN101033250A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 09/12/2007 | CN100336826C N-acyl-aspartic acid-beta-dipeptide derivatives preparing process |
| 09/11/2007 | US7268211 Removal of ruthenium by-product by supercritical fluid processing |
| 09/11/2007 | US7268209 Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7267983 peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins formulated in culture medium to produce the desired effect on cultured cells; useful in concatemer-based recombinant expression methods |
| 09/11/2007 | CA2115355C Novel tetrapeptide derivative |
| 09/07/2007 | WO2007099650A1 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/07/2007 | WO2007065638A3 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 09/07/2007 | WO2006020541A3 Methods for synthesizing polypeptides |
| 09/07/2007 | CA2644552A1 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 09/06/2007 | US20070207527 Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors |
| 09/05/2007 | EP1828386A1 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents |
| 09/05/2007 | EP1828246A1 Myd88 homodimerization inhibitors |
| 09/05/2007 | EP1828243A2 Growth hormone secretagogue receptor 1a ligands |
| 09/05/2007 | EP1828117A1 Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives |
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | CN101029080A Methods and compositions for derepression of IAP-inhibited caspase |
| 09/04/2007 | US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 09/04/2007 | US7264932 Nuclease inhibitor cocktail |
| 08/30/2007 | WO2007097903A2 Hiv fusion inhibitor peptides with improved biological properties |
| 08/30/2007 | WO2007096182A1 Pcr hot start by magnesium sequestration |
| 08/30/2007 | WO2007095980A1 Modified amino acids |
| 08/30/2007 | US20070203325 Integrase-dirived HIV-inhibiting agents |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/30/2007 | US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 08/30/2007 | US20070202127 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 08/30/2007 | US20070202123 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids |
| 08/29/2007 | EP1826199A1 Modified amino acids |
| 08/29/2007 | EP1824873A1 Use of derivatives of dipeptides for the manufacture of a medicament for the treatment of microbial infections |
| 08/29/2007 | EP1824501A1 Protein hydrolysate with antidiabetic effect |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/28/2007 | US7262269 Screening cancer ligands; polypeptide for binding to cancer cells |
| 08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
| 08/28/2007 | US7262184 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| 08/28/2007 | US7262169 Process for preparing peptide intermediates |
| 08/28/2007 | CA2367755C Dimeric compounds and their use as inhibitors of neuraminidase |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/23/2007 | WO2007093839A1 New polypeptides kxk and their use |
| 08/23/2007 | WO2006126086A3 Angiotensin i - converting enzyme (ace) inhibitors |
| 08/23/2007 | US20070197772 Methods for preparing internally constrained peptides and peptidomimetics |
| 08/23/2007 | US20070197465 Hyaluronic Acid-Methotrexate Conjugate |
| 08/23/2007 | US20070197448 such as 2-Methyl-propane-2-sulfinic acid cyclohexylideneamide; coadministered with ribavirin, interferons |